Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Neogen Corporation
Neogen Corporation News
Jun 28, 2025 - globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Jun 27, 2025 - prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Jun 25, 2025 - businesswire.com
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Jun 24, 2025 - businesswire.com
Neogen Corporation (NEOG) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Neogen Corporation Quantitative Score

About Neogen Corporation
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Neogen Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Neogen Corporation Financials
Table Compare
Compare NEOG metrics with: | |||
---|---|---|---|
Earnings & Growth | NEOG | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | NEOG | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | NEOG | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | NEOG | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Neogen Corporation Income
Neogen Corporation Balance Sheet
Neogen Corporation Cash Flow
Neogen Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Strong Sell |
Return on Assets | Strong Sell |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Neogen Corporation Executives
Name | Role |
---|---|
Mr. John Edward Adent | President, Chief Executive Officer & Director |
Mr. David H. Naemura | Chief Operating Officer & Chief Financial Officer |
Ms. Amy M. Rocklin Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Dr. Jason W. Lilly M.B.A., Ph.D. | Chief Scientific Officer |
Mr. Bill Waelke | Head of Investor Relations |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. John Edward Adent | President, Chief Executive Officer & Director | Male | 1968 | 1.22M |
Mr. David H. Naemura | Chief Operating Officer & Chief Financial Officer | Male | 1970 | 810.65K |
Ms. Amy M. Rocklin Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary | Female | 1972 | 564.7K |
Dr. Jason W. Lilly M.B.A., Ph.D. | Chief Scientific Officer | 1974 | 476.99K | |
Mr. Bill Waelke | Head of Investor Relations | Male | -- |
Neogen Corporation Insider Trades
Date | 2 Jun |
Name | Wainer Andrea F |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 6090 |
Date | 2 Jun |
Name | Wainer Andrea F |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 16303 |
Date | 1 Jun |
Name | Wainer Andrea F |
Role | Director |
Transaction | Disposed |
Type | |
Shares | 0 |
Date | 2 Jun |
Name | Naemura David H. |
Role | Chief Financial Officer |
Transaction | Acquired |
Type | A-Award |
Shares | 52724 |
Date | 2 Jun |
Name | Naemura David H. |
Role | Chief Financial Officer |
Transaction | Acquired |
Type | A-Award |
Shares | 211723 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
2 Jun | Wainer Andrea F | Director | Acquired | A-Award | 6090 |
2 Jun | Wainer Andrea F | Director | Acquired | A-Award | 16303 |
1 Jun | Wainer Andrea F | Director | Disposed | 0 | |
2 Jun | Naemura David H. | Chief Financial Officer | Acquired | A-Award | 52724 |
2 Jun | Naemura David H. | Chief Financial Officer | Acquired | A-Award | 211723 |